Teleflex Stock

Teleflex EBITDA per Employee

The EBITDA per Employee of Teleflex (TFX) as of Sep 6, 2026 is 17,764.17 USD. In the previous year, EBITDA per Employee was 11,043.19 USD — a change of 60.86% (higher).

EBITDA per Employee

17,764.17USD

YoY

60.86%

Last updated:

EBITDA per Employee of Teleflex is 2026 17,764.17 USD. EBITDA per Employee of Teleflex was 2025 11,043.19 USD. It decreases by 60.86% higher compared to the previous year.

The Teleflex EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
22,340.56 USD
Jan 1, 2019
29,670.42 USD
Jan 1, 2020
29,379.72 USD
Jan 1, 2021
43,617.71 USD
Jan 1, 2022
39,321.18 USD
Jan 1, 2023
35,160.63 USD
Jan 1, 2024
11,043.19 USD
Jan 1, 2025
17,764.17 USD
The Teleflex EBITDA per Employee history
YEAREBITDA per EmployeeYoY
17,764.17USD+60.86%
11,043.19USD-68.59%
35,160.63USD-10.58%
39,321.18USD-9.85%
43,617.71USD+48.46%
29,379.72USD-0.98%
29,670.42USD+32.81%
22,340.56USD-13.59%
25,852.71USD+16.54%
22,184.24USD+1.13%
21,936.88USD+10.89%
19,782.08USD
Access this data via the Eulerpool API

Teleflex Stock analysis

What does Teleflex do? Teleflex Inc. is a global company founded in 1943. The company is headquartered in Wayne, Pennsylvania, USA and operates in over 40 countries worldwide. It is a leading provider of medical devices, instruments, and accessories for various applications in clinical practice and patient care. The business model of Teleflex is based on the manufacturing and marketing of medical devices and instruments, particularly in the areas of anesthesia, vascular access, interventional medicine, pulmonary and thoracic surgery, urological care, cardiovascular diagnostics, and surgery. The company works closely with medical professionals and clinicians to develop high-quality products that meet the needs of patients and doctors. Teleflex is divided into several business segments, including angiography/diagnostics, anesthesia, oncology, vascular intervention, pulmonology, surgery, and urology. Each of these segments offers a wide range of products and solutions specifically tailored to the needs of doctors and patients. In the angiography/diagnostics segment, Teleflex offers a variety of products that can be used for the diagnosis and treatment of cardiovascular diseases and other medical conditions. These include catheters, guide wires, and sheaths. The anesthesia segment of Teleflex includes products such as ventilation bags, endotracheal tubes, and nebulizer systems. These products are essential for the successful performance of anesthesia procedures and can help doctors save valuable time and resources. The oncology segment of Teleflex offers a wide range of products specifically designed for the treatment of cancer patients. These include catheter-based systems that can facilitate the administration of drugs and other therapies. With the vascular intervention segment, Teleflex offers a comprehensive range of products and solutions specifically designed for the treatment of vascular diseases. These include balloon catheters, stents, and sheaths. The pulmonology segment of Teleflex offers products aimed at facilitating breathing and improving the quality of life for patients with chronic respiratory diseases. These include oxygen concentrators, tracheal tubes, and ventilators. The surgical segment of Teleflex offers a variety of solutions for performing surgical procedures, including surgical instruments, sutures, and wound care materials. The urology segment of Teleflex offers a wide range of products specifically designed for use in urology. These include catheters, wires, and stents. Teleflex is a leading company in the medical technology industry that specializes in the development and marketing of products that improve patients' quality of life and facilitate the work of doctors. With its innovative solutions and a focus on providing the best possible customer service and patient safety, Teleflex has taken on a significant role in the industry and will continue to be an important provider in this market in the future. Teleflex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Teleflex stock

EBITDA per Employee of Teleflex is 17,764.17 USD in 2026.

EBITDA per Employee of Teleflex changed from 11,043.19 USD to 17,764.17 USD, representing a 60.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Teleflex since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Teleflex historically and in real time.

Access this data via the Eulerpool API

Workforce — Teleflex

All Key Metrics — Teleflex